CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs).

[1]  R. Somasundaram,et al.  Chemokines and the microenvironment in neuroectodermal tumor-host interaction. , 2009, Seminars in cancer biology.

[2]  I. Parney,et al.  Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation. , 2009, Journal of neurosurgery.

[3]  R. Thompson,et al.  CXCR4 mediates the proliferation of glioblastoma progenitor cells. , 2009, Cancer letters.

[4]  Y. Marie,et al.  Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  W. Rostène,et al.  Chemokine Action in the Nervous System , 2008, The Journal of Neuroscience.

[6]  V. Gieselmann,et al.  The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6 , 2008, Molecular and Cellular Neuroscience.

[7]  J. Kuratsu,et al.  Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas , 2008, The Journal of pathology.

[8]  J. Van Damme,et al.  The role of CXC chemokines and their receptors in cancer. , 2008, Cancer letters.

[9]  A. Ludwig,et al.  Glial cross-talk by transmembrane chemokines CX3CL1 and CXCL16 , 2008, Journal of Neuroimmunology.

[10]  W. Streit,et al.  CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes , 2008, Journal of Neuroimmunology.

[11]  H. Mehdorn,et al.  Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas , 2008, Glia.

[12]  R. Strieter,et al.  Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. , 2007, Cancer research.

[13]  D. Patel,et al.  Defective antitumor responses in CX3CR1‐deficient mice , 2007, International journal of cancer.

[14]  S. Bevan,et al.  Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.

[15]  C. Weber,et al.  Regulated Shedding of Transmembrane Chemokines by the Disintegrin and Metalloproteinase 10 Facilitates Detachment of Adherent Leukocytes1 , 2007, The Journal of Immunology.

[16]  C. Weber,et al.  Transmembrane chemokines: Versatile ‘special agents’ in vascular inflammation , 2007, Thrombosis and Haemostasis.

[17]  A. Zlotnik.  Chemokines and cancer , 2006, International journal of cancer.

[18]  A. Ben-Baruch.  The multifaceted roles of chemokines in malignancy , 2006, Cancer and Metastasis Reviews.

[19]  H. Mehdorn,et al.  Cannabinoid receptors in human astroglial tumors , 2006, Journal of neurochemistry.

[20]  Steffen Jung,et al.  Control of microglial neurotoxicity by the fractalkine receptor , 2006, Nature Neuroscience.

[21]  David J. Yang,et al.  The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. , 2006, Neuro-oncology.

[22]  P. Kabos,et al.  CXCR4 expression mediates glioma cell invasiveness , 2006, Oncogene.

[23]  S. Hwang,et al.  Chemokines, chemokine receptors, and cancer metastasis , 2006, Journal of leukocyte biology.

[24]  Chuanshu Huang,et al.  Inflammation, a Key Event in Cancer Development , 2006, Molecular Cancer Research.

[25]  David J. Yang,et al.  Innate immune functions of microglia isolated from human glioma patients , 2006, Journal of Translational Medicine.

[26]  Nico van Rooijen,et al.  Microglia Stimulate the Invasiveness of Glioma Cells by Increasing the Activity of Metalloprotease-2 , 2005, Journal of neuropathology and experimental neurology.

[27]  H. Lassmann,et al.  CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin , 2005, Journal of Neuroinflammation.

[28]  K. Reiss,et al.  Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells , 2005, Journal of neurochemistry.

[29]  Huqun,et al.  Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells , 2005, European journal of immunology.

[30]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[31]  N. Dolloff,et al.  CX3CR1-Fractalkine Expression Regulates Cellular Mechanisms Involved in Adhesion, Migration, and Survival of Human Prostate Cancer Cells , 2004, Cancer Research.

[32]  Francesca Aloisi,et al.  Chemokines and Glial Cells: A Complex Network in the Central Nervous System , 2004, Neurochemical Research.

[33]  Andrew L Kung,et al.  A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Ravid,et al.  CX3CL1 and CX3CR1 Expression in Human Brain Tissue: Noninflammatory Control versus Multiple Sclerosis , 2003, Journal of neuropathology and experimental neurology.

[35]  F. Fahrenholz,et al.  The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. , 2003, Blood.

[36]  J. S. Rao,et al.  Molecular mechanisms of glioma invasiveness: the role of proteases , 2003, Nature Reviews Cancer.

[37]  H. Hartung,et al.  CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system , 2003, Journal of Neuroimmunology.

[38]  G. Arendt,et al.  Increased intrathecal release of soluble fractalkine in HIV-infected patients. , 2003, AIDS research and human retroviruses.

[39]  V. Wee Yong,et al.  CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival* , 2002, The Journal of Biological Chemistry.

[40]  K. Reiss,et al.  Stromal cell-derived factor 1 is secreted by meningeal cells and acts as chemotactic factor on neuronal stem cells of the cerebellar external granular layer , 2002, Neuroscience.

[41]  A. Nagai,et al.  Fractalkine and fractalkine receptors in human neurons and glial cells , 2002, Journal of neuroscience research.

[42]  V. Perry,et al.  Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS , 2002, Glia.

[43]  C. Blobel,et al.  Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). , 2001, The Journal of biological chemistry.

[44]  F. Davis,et al.  Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. , 2001, Neuro-oncology.

[45]  T. Matsumiya,et al.  Synergistic stimulation, by tumor necrosis factor-α and interferon-γ, of fractalkine expression in human astrocytes , 2001, Neuroscience Letters.

[46]  K. Moores,et al.  Fractalkine Cleavage from Neuronal Membranes Represents an Acute Event in the Inflammatory Response to Excitotoxic Brain Damage , 2000, The Journal of Neuroscience.

[47]  B. Badie,et al.  Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. , 2000, Neurosurgery.

[48]  R. Maki,et al.  Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. , 1999, Journal of immunology.

[49]  T. Mikkelsen,et al.  Increased SPARC expression promotes U87 glioblastoma invasion in vitro , 1999, International Journal of Developmental Neuroscience.

[50]  W. Streit,et al.  Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  A. Akaike,et al.  Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? , 1998, FEBS letters.

[52]  T. Schall,et al.  Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.

[53]  Wei Wang,et al.  A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.

[54]  A. Giuditta,et al.  β-Actin and β-Tubulin are components of a heterogeneous mRNA population present in the squid giant axon , 1992, Molecular and Cellular Neuroscience.

[55]  Yu Liang,et al.  CC chemokine receptor-2A is frequently overexpressed in glioblastoma , 2007, Journal of Neuro-Oncology.

[56]  A. Grosu,et al.  Combined modality treatment of glioblastoma multiforme: the role of temozolomide. , 2006, Reviews on recent clinical trials.